1. Home
  2. KGC vs RMD Comparison

KGC vs RMD Comparison

Compare KGC & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kinross Gold Corporation

KGC

Kinross Gold Corporation

N/A

Current Price

$20.76

Market Cap

28.3B

ML Signal

N/A

Logo ResMed Inc.

RMD

ResMed Inc.

N/A

Current Price

$239.70

Market Cap

33.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KGC
RMD
Founded
1993
1989
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3B
33.6B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
KGC
RMD
Price
$20.76
$239.70
Analyst Decision
Buy
Buy
Analyst Count
18
20
Target Price
$30.68
★ $264.33
AVG Volume (30 Days)
★ 7.8M
1.4M
Earning Date
10-28-2026
10-29-2026
Dividend Yield
0.77%
★ 1.10%
EPS Growth
N/A
★ 9.67
EPS
N/A
★ 2.92
Revenue
N/A
★ $2,957,013,000.00
Revenue This Year
$18.92
$3.12
Revenue Next Year
$8.00
$6.43
P/E Ratio
★ $24.18
$81.88
Revenue Growth
N/A
★ 13.44
52 Week Low
$19.70
$180.27
52 Week High
$39.11
$277.67

Technical Indicators

Market Signals
Indicator
KGC
RMD
Relative Strength Index (RSI) 38.90 52.90
Support Level $19.70 $218.45
Resistance Level $24.74 $257.89
Average True Range (ATR) 0.75 7.36
MACD 0.08 -0.87
Stochastic Oscillator 29.37 56.48

Price Performance

Historical Comparison
KGC
RMD

About KGC Kinross Gold Corporation

Kinross Gold is a Canada-based gold producer, producing roughly 2 million gold equivalent ounces in 2025. The company had about a decade of gold reserves at the end of 2025. It operates mines in the Americas and West Africa after selling its low-cost Russian operations in 2022 in response to the invasion of Ukraine. Kinross has historically used acquisitions to fuel expansion into new regions and production growth. In 2022, Kinross purchased the Great Bear project in Canada. If developed as we think likely, it could produce an average of more than 500,000 ounces of gold per year for at least a decade, with its unit cash costs likely in the first quartile of the industry cost curve. Though Great Bear's production is likely to be replacement ounces for falling volumes at other mines.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: